325 related articles for article (PubMed ID: 18413214)
1. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.
Kadiroglu AK; Sit D; Kayabasi H; Tuzcu AK; Tasdemir N; Yilmaz ME
J Diabetes Complications; 2008; 22(4):241-5. PubMed ID: 18413214
[TBL] [Abstract][Full Text] [Related]
2. Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL.
Guldiken S; Guldiken B; Arikan E; Altun Ugur B; Kara M; Tugrul A
Diabetes Nutr Metab; 2004 Aug; 17(4):247-9. PubMed ID: 15575347
[TBL] [Abstract][Full Text] [Related]
3. Venlafaxine in the treatment of painful peripheral diabetic neuropathy in a uremic patient undergoing hemodialysis.
Yilmaz ME; Kadiroglu AK; Kara IH; Dikici S
MedGenMed; 2002 Aug; 4(3):23. PubMed ID: 12466766
[No Abstract] [Full Text] [Related]
4. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.
Halawa MR; Karawagh A; Zeidan A; Mahmoud AE; Sakr M; Hegazy A
Curr Med Res Opin; 2010 Feb; 26(2):337-43. PubMed ID: 19968592
[TBL] [Abstract][Full Text] [Related]
6. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study.
Atli A; Dogra S
Pain Med; 2005; 6(3):225-34. PubMed ID: 15972086
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy.
Tamburin S; Zanette G
Pain Med; 2009 Nov; 10(8):1476-80. PubMed ID: 19788714
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
Youle M; Osio M;
HIV Med; 2007 May; 8(4):241-50. PubMed ID: 17461852
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.
Backonja M; Beydoun A; Edwards KR; Schwartz SL; Fonseca V; Hes M; LaMoreaux L; Garofalo E
JAMA; 1998 Dec; 280(21):1831-6. PubMed ID: 9846777
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
[TBL] [Abstract][Full Text] [Related]
11. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.
Murrey D; Janssen M; Delamarter R; Goldstein J; Zigler J; Tay B; Darden B
Spine J; 2009 Apr; 9(4):275-86. PubMed ID: 18774751
[TBL] [Abstract][Full Text] [Related]
12. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes.
Daousi C; MacFarlane IA; Woodward A; Nurmikko TJ; Bundred PE; Benbow SJ
Diabet Med; 2004 Sep; 21(9):976-82. PubMed ID: 15317601
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial.
Santamato A; Solfrizzi V; Panza F; Tondi G; Frisardi V; Leggin BG; Ranieri M; Fiore P
Phys Ther; 2009 Jul; 89(7):643-52. PubMed ID: 19482902
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy.
Otto M; Bach FW; Jensen TS; Sindrup SH
Eur J Pain; 2007 Jul; 11(5):572-8. PubMed ID: 17049890
[TBL] [Abstract][Full Text] [Related]
15. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
Wymer JP; Simpson J; Sen D; Bongardt S;
Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
19. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
Miner JR; Moore J; Gray RO; Skinner L; Biros MH
Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 3 needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomized controlled trial.
Yoon SH; Rah UW; Sheen SS; Cho KH
Arch Phys Med Rehabil; 2009 Aug; 90(8):1332-9. PubMed ID: 19651267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
